Report Id: SNS/HC/1203 | May 2022 | Region: Global | 125 Pages
Report Scope & Overview:
The Urinalysis Market Size was valued at USD 3.8 billion in 2021 and is expected to reach USD 6.2 billion by 2028, and grow at a CAGR of 7% over the forecast period 2022-2028.
Urinalysis is a urine sample analysis test that aids in the detection of a variety of conditions like diabetes, kidney disease, and urinary tract infection. Its main goal is to keep track of people's health. Urinalysis is performed as part of a general medical check-up, as part of pre-surgery preparation, as part of a pregnancy check-up, or as part of a hospital admission for various diseases. It also aids in determining the source of symptoms like back pain, abdominal pain, and uncomfortable urination.
The increasing frequency of kidney illnesses, the adoption of PPACA, and the growing geriatric population are all factors driving the global urinalysis market forward. Meanwhile, the US government's imposition of an excise tax and strong regulations procedures are limiting the market's expansion. Integrated systems and urinalysis via cellphones, as well as technical advancements, give business potential.
The elderly population is growing.
Urinary parcel disease is turning out to be more normal.
Constant renal illness is turning out to be more normal over the world.
Reimbursement situation that is not favourable
Urinalysis growth possibilities in developing economies
Development of technology in urinalysis
The supervisory environment could make growth even more difficult.
IMPACT OF COVID-19
The COVID-19 epidemic had a negative impact on most businesses' overall sales. Lockdowns arising from the COVID-19 epidemic forced people to put off getting their health checked, reducing the amount of tests conducted and reagent sales. Nevertheless, as governments gradually loosen travel restrictions, there is a rebound in testing numbers. People hospitalized with COVID-19 are at a high risk of AKI, which can lead to serious illness, dialysis, and even death, as per the National Kidney Foundation.
The reclaimed COVID-19 people with AKI or ARF (acute renal failure) should see a kidney doctor on a frequent basis because their risk of chronic kidney disease is more than others. Patients with COVID-19 who did not develop AKI but had blood or protein in their urine should be closely watched because they have a greater risk of getting the chronic and end-stage renal disease. With the COVID-19 pandemic, there is an increasing desire for the development of more accurate and simple testing methods, as well as the growth of testing structures, in addition to vaccinations and therapeutic medications.
As governments and healthcare providers confront extraordinary problems, COVID-19 has an impact on the regulatory environment and practises. Government regulators used a variety of techniques to expedite the approval of diagnostic products. Organizations have gone with vital choices to execute COVID-19 fast tests, keep up with income, and moderate COVID-19's effect on their working abilities.
The worldwide urinalysis market is separated into the product, test type, application, end client. The dipstick, reagent, urine analyzer, and POC product segments are further divided. Biochemical, sediment, and microscopic tests are addressed in the study. The paper covers diagnosis, diabetes, urinary tract infections, kidney disease, and pregnancy. The report's end consumers include homes, hospitals, and research organizations.
Some of the major key players are as follows are Roche Diagnostics, Siemens Healthcare, Sysmex Corporation, Elektronika KFT, Arkray Inc., Beckman Coulter Inc., Roche Diagnostics, Mindray Medical International Limited, URIT Medical Electronic Group Co. Ltd., Acon Laboratories Inc., Bio-Rad Laboratories Inc, and other players.
KEY MARKET SEGMENTS:
By Product Type
Pregnancy & Fertility Kits
Automated Urine Analyzers
Point-of-Care Urine Analyzers
Semi-automated Urine Analyzers
Pregnancy & Fertility Tests
Urinary Tract Infections
Pregnancy and Fertility
By End User
Home Care Settings
Hospitals and Clinics
North America, Europe, Asia Pacific, and the Rest of the World make up the urinalysis market. North America held the highest proportion of the worldwide urinalysis market in 2021. The growing elderly population, implementation of favourable government programmes, increased healthcare expenditure, improved healthcare infrastructure, and the availability of technologically advanced instruments all contribute to the growth of the North American urinalysis market.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
|Market Size in 2021||US$ 3.8 Billion|
|Market Size by 2028||US$ 6.2 Billion|
|CAGR||CAGR of 7% From 2022 to 2028|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Product Type (Consumables (Pregnancy & Fertility Kits, Reagents, Dipsticks, Disposables)
• By Instruments (Automated Urine Analyzers, Point-of-Care Urine Analyzers, Semi-automated Urine Analyzers)
• By Test (Pregnancy & Fertility Tests, Sediment Urinalysis, Biochemical Urinalysis)
• By Application (Disease Screening, Pregnancy and Fertility)
• By End User (Diagnostic Laboratories, Home Care Settings, Research Laboratories, Hospitals and Clinics)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Roche Diagnostics, Siemens Healthcare, Sysmex Corporation, Elektronika KFT, Arkray Inc., Beckman Coulter Inc., Roche Diagnostics, Mindray Medical International Limited, URIT Medical Electronic Group Co. Ltd., Acon Laboratories Inc., Bio-Rad Laboratories Inc, and other players.|
|DRIVERS||• The elderly population is growing.
• Urinary parcel disease is turning out to be more normal.
• Constant renal illness is turning out to be more normal over the world.
|RESTRAINTS||• Reimbursement situation that is not favourable|
Frequently Asked Questions (FAQ) :
The urinalysis market is expected to grow at a CAGR of 7% over the forecast period 2022-2028.
The reimbursement situation that is not favorable is the restraints of the Urinalysis market.
The urinalysis Market is divided into four segments and they are By Product Type, By Test Type, By Application Type, and, By End User Type
North America held the highest proportion of the urinalysis market.
Manufacturer and service provider, research institutes, universities, and private libraries, suppliers, and distributors.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID 19 Impact Analysis
4.2 Impact of Ukraine ware
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8 Urinalysis market Segmentation, by Product Type
8.1.1 Pregnancy & Fertility Kits
8.2.1 Automated Urine Analyzers
8.2.3 Point-of-Care Urine Analyzers
8.2.4 Semi-automated Urine Analyzers
9. Urinalysis market Segmentation, By Test Type
9.1 Pregnancy & Fertility Tests
9.2 Sediment Urinalysis
9.3 Biochemical Urinalysis
9.3.1 POC Tests
9.3.2 Laboratory Tests
10. Urinalysis market Segmentation, By Application Type
10.1 Disease Screening
10.1.1 Urinary Tract Infections
10.1.2 Liver Diseases
10.1.3 Kidney diseases
10.2 Pregnancy and Fertility
11. Urinalysis market Segmentation, By End User Type
11.1 Diagnostic Laboratories
11.2 Home Care Settings
11.3 Research Laboratories
11.4 Hospitals and Clinics
12. Regional Analysis
12.2 North America
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4.2 South Korea
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.3 South Africa
12.6 Latin America
12.6.3 Rest of Latin America
13. Company Profiles
13.1 Roche Diagnostics
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.2 Siemens Healthcare
13.3 Sysmex Corporation
13.4 Elektronika KFT
13.5 Arkray Inc.
13.6 Beckman Coulter Inc.
13.7 Roche Diagnostics
13.8 Mindray Medical International Limited
13.9 URIT Medical Electronic Group Co. Ltd.
13.10 Acon Laboratories Inc.
13.11 Bio-Rad Laboratories Inc.
14. Competitive Landscape
14.1 Competitive Benchmark
14.2 Market Share analysis
14.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of a good and accurate research report and selecting the best methodology to complete the research is the toughest part. Since the research reports, we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach a stage wherein we can provide our clients best and most accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brainstorming sessions to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research as the name suggests is a research process wherein, we collect data through readily available information. In this process, we use various paid and unpaid databases to which our team has access and gather data through the same. This includes examining listed companies’ annual reports, Journals, SEC filling, etc. Apart from this, our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various universities as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content-specific facts that can be sued to solve specific problems. Since the collected data is fresh and first-hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply sides of the industry to make sure we land an accurate judgment and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses, and observation of on-field participants. The below-mentioned chart should give a better understanding of part 1 of the primary interview.
Part 2: In this part of the primary research the data collected via secondary research and part 1 of the primary research is validated with the interviews with individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence center, our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real-time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but is not limited to getting rid of the many typos, duplication of numbers, or missing any important information. The people involved in this process include technical content writers, research heads, and graphics people. Once this process is completed the title gets uploaded on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.